235 - Early Institutional Experience with Online Adaptive Radiotherapy in Latin America: Workflow Time Analysis
Presenter(s)
M. D. De La Mata Moya1, G. Cuamani1, M. Hernandez-Bojorquez2, R. C. Ronquillo Gomez3, D. N. Briceno Guel3, A. S. Ramirez Estudillo4, A. A. Martinez Gomez3, I. Martinez Oliver3, L. K. Sanchez Colin3, J. R. Miranda Garcia3, J. E. Morales Nolasco3, I. O. Ayala Iturbe3, K. M. Ojeda Soto3, and R. Sanchez Castro3; 1Centro Medico ABC, Mexico City, Mexico, 2Centro Médico ABC, Mexico City, DF, Mexico, 3Centro Medico ABC, Mexico CIty, Mexico, 4Centro Medico ABC, Mexico City, DF, Mexico
Purpose/Objective(s):
Report the initial institutional experience with online adaptive radiotherapy (ART), focusing on detailed workflow time metrics. This represents the first clinical integration of online ART in Latin America.Materials/Methods:
Between July/2025-January/2026, a total of 22 patients (p.) treated with online ART (298 delivered fractions): Stereotactic Body Radiation Therapy (SBRT) and conventional or moderate hypofractionated (Conv/Hypo) treatments were included. Workflow time metrics were prospectively collected. For all fractions: patient set-up time, beam delivery time, and door-to-door time, were recorded. A subset of eight patients (97 fractions) was comprehensively analyzed to extract adaptive workflow components, including autocontouring of organs at risk (OARs), influencers, and targets (review and editing); real-time dose calculation; and secondary verification. Intensity-Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) techniques were included. Summary measures were calculated using the mean per patient for statistical analysis.Results:
Patient distribution was as follows: 16 p. (72.7%) were male and 6p. (27.3%) were female. Nine patients received SBRT, while 13p. underwent Conv/Hyp. Among Conv/Hyp treatments, the most frequently treated primary tumors were prostate, gynecologic, and head and neck cancers. In the SBRT cohort, the most common treatment sites were liver, nodal disease, and prostate. Treatment time analysis is detailed in Table 1. Mean door-to-door treatment times were 21.3 minutes (min.) for IMRT and 23.1 min. for VMAT in the Conv/Hyp group, and 34.3 minutes for IMRT and 39.7 minutes for VMAT in the SBRT group. The use of adaptive tools increased treatment time by approximately 11 minutes in the Conv/Hyp cohort and 18 min for SBRT group.Conclusion:
Online ART workflow duration varies according to fractionation, treatment technique, operator expertise, tumor site, and patient-specific factors. The treatment times observed during this initial eight-month experience are consistent with ranges reported by international centers. These findings support the feasibility and clinical integration of online ART in a Latin American. Abstract 235 - Table 1| Set-up time | Segmentation | Dose calculation | Verification | Beam delivery | Door to door | ||||||||
| Mean | Median | Mean | Median | Mean | Median | Mean | Median | Mean | Median | Mean | Median | ||
| Conv/Hypo | IMRT | 6 (+-2,7) | 4,7 | 5 (+-1,7) | 4,5 | 4,6 (+-0,4) | 4,4 | 2,2 (+-0,4) | 2,35 | 3,3 (+-1) | 3,03 | 21,9 (+-3,3) | 21,3 |
| VMAT | 3,6 (+-2) | 3,08 | 4,4 (+-2,1) | 3,4 | 7,2 (+-2,3) | 6,4 | 1,8 (+-0,5) | 1,62 | 3,3 (+-3,3) | 2,7 | 22,6 (+-1,2) | 23,1 | |
| SBRT | IMRT | 12,8 (+-4,9) | 11,39 | 11,9 (+- 2,3) | 11.8 | 7,3 (+-1,5) | 7,0 | - | - | 4,9 (+-1,9) | 4,2 | 36,6 (+-7,6) | 34,34 |
| VMAT | 13,1 (+-1) | 13,2 | 9,0 (+- 1,2) | 9,0 | 8,5 +- (0.42) | 8,5 | - | - | 2,7 (+-0,5) | 2,8 | 38,4 (+-6,2) | 39,7 | |